Managed Account Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$80.4M Buy
758,561
+49,453
+7% +$5.47M 0.07% 307
2015
Q1
$80.9M Buy
709,108
+8,646
+1% +$986K 0.07% 295
2014
Q4
$77.1M Buy
700,462
+25,276
+4% +$2.66M 0.08% 303
2014
Q3
$65.9M Sell
675,186
-30,528
-4% -$3M 0.07% 321
2014
Q2
$71.2M Buy
705,714
+26,054
+4% +$2.54M 0.09% 282
2014
Q1
$62.4M Sell
679,660
-290,014
-30% -$26.7M 0.08% 292
2013
Q4
$87.7M Buy
969,674
+43,414
+5% +$3.76M 0.12% 215
2013
Q3
$73.9M Sell
926,260
-66,507
-7% -$5.24M 0.11% 224
2013
Q2
$72.2M Buy
+992,767
New +$74.2M 0.11% 211

Other funds holding ZBH

Managed Account Advisors's ZBH Position: Q2 2015 in Review

Managed Account Advisors increased its Zimmer Biomet (ZBH) stake by 7% in Q2 2015, buying an estimated $5.47M and bringing the position to 758,561 shares worth $80.4M. The position accounts for 0.07% of the portfolio, ranked #307.

Managed Account Advisors first reported a position in ZBH in Q2 2013 and has held it in 9 quarters since. The position peaked at $87.7M in Q4 2013. 750 funds tracked by Wall St. Rank hold ZBH as of Q2 2015.

  • Managed Account Advisors held 758,561 shares of Zimmer Biomet worth $80.4M as of Q2 2015.
  • Managed Account Advisors bought 49,453 Zimmer Biomet shares in Q2 2015, an estimated $5.47M.
  • Zimmer Biomet made up 0.07% of Managed Account Advisors's portfolio in Q2 2015, its #307 holding.
  • Managed Account Advisors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 9 quarters since.
  • Managed Account Advisors's Zimmer Biomet position peaked at $87.7M in Q4 2013.
  • 750 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.